Targeted agent shows promise in biliary cancer study

COLUMBUS, Ohio - An experimental agent has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at the Ohio State University. The agent, known as AZD6244 (ARRY-142886), blocks certain enzymes that cancer cells need to proliferate and survive.

Read the whole article on Science Blog

More from Science Blog